Literature DB >> 8072254

Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis.

R K Detwiler1, R J Falk, S L Hogan, J C Jennette.   

Abstract

Sixteen patients with renal biopsy findings of extensive focal glomerular capillary collapse, visceral epithelial cell hypertrophy and hyperplasia, and variable degrees of tubulointerstitial injury in the absence of evidence for human immunodeficiency virus (HIV) infection or intravenous drug abuse were prospectively identified by renal biopsy. The pathologic process was designated collapsing glomerulopathy to distinguish it from other patterns of focal glomerular sclerosis. The clinical and pathologic characteristics of these 16 patients were analyzed and compared to a group of 25 patients with noncollapsing focal segmental glomerulosclerosis (FSGS). Thirteen of 16 patients with collapsing glomerulopathy were black as compared with 11 of 25 with FSGS (P = 0.018). The most common findings at presentation were hypertension and manifestations of the nephrotic syndrome. Although the duration of symptoms prior to presentation was no longer in the collapsing glomerulopathy group, the presenting mean serum creatinine was higher in patients with collapsing glomerulopathy than in those with noncollapsing FSGS (3.5 +/- 3.4 mg/dl vs. 1.3 0.6 mg/dl, P = 0.001). Twenty-four-hour urine protein excretion was also higher in the collapsing glomerulopathy group (13.2 +/- 7.7 g/day vs. 4.6 +/- 4.5 g/day FSGS, P = 0.005). The collapsing glomerulopathy patients had a mean age of 41.4 +/- 19.1 (range 19 to 81), a male-to-female ratio of 11:5 and a black-to-white ratio of 13:3. Renal survival, evaluated by life-table analysis, was markedly worse in collapsing glomerulopathy patients than in FSGS patients (P = 0.0004). It is proposed that collapsing glomerulopathy is a distinct entity characterized by black racial predominance, massive proteinuria, relatively rapidly progressive renal insufficiency, and distinctive pathologic findings.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 8072254     DOI: 10.1038/ki.1994.185

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  58 in total

1.  Focal segmental glomerulosclerosis and parvovirus B19.

Authors:  Catalina Sanchez; Andrew Fenves; John Schwartz
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-01

2.  Idiopathic collapsing focal segmental glomerulosclerosis in pediatric patients.

Authors:  Ahmed M El-Refaey; Gaurav Kapur; Amrish Jain; Guillermo Hidalgo; Abubakr Imam; Rudolph P Valentini; Tej K Mattoo
Journal:  Pediatr Nephrol       Date:  2006-12-06       Impact factor: 3.714

Review 3.  Collapsing glomerulopathy in systemic autoimmune disorders: a case occurring in the course of full blown systemic lupus erythematosus.

Authors:  Z Amoura; S Georgin-Lavialle; J Haroche; D Merrien; I Brocheriou; H Beaufils; J-C Piette
Journal:  Ann Rheum Dis       Date:  2006-02       Impact factor: 19.103

4.  Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells.

Authors:  Bart Smeets; Sandra Uhlig; Astrid Fuss; Fieke Mooren; Jack F M Wetzels; Jürgen Floege; Marcus J Moeller
Journal:  J Am Soc Nephrol       Date:  2009-11-16       Impact factor: 10.121

5.  Collapsing focal segmental glomerulosclerosis: Current concepts.

Authors:  Muhammed Mubarak
Journal:  World J Nephrol       Date:  2012-04-06

6.  Association of histologic variants in FSGS clinical trial with presenting features and outcomes.

Authors:  Vivette D D'Agati; Joan M Alster; J Charles Jennette; David B Thomas; James Pullman; Daniel A Savino; Arthur H Cohen; Debbie S Gipson; Jennifer J Gassman; Milena K Radeva; Marva M Moxey-Mims; Aaron L Friedman; Frederick J Kaskel; Howard Trachtman; Charles E Alpers; Agnes B Fogo; Tom H Greene; Cynthia C Nast
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-06       Impact factor: 8.237

7.  Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.

Authors:  Dominick Santoriello; Syed A Husain; Sacha A De Serres; Andrew S Bomback; Russell J Crew; Elena-Rodica Vasilescu; Geo Serban; Eric S Campenot; Krzysztof Kiryluk; Sumit Mohan; Gregory A Hawkins; Pamela J Hicks; David J Cohen; Jai Radhakrishnan; Michael B Stokes; Glen S Markowitz; Barry I Freedman; Vivette D D'Agati; Ibrahim Batal
Journal:  Kidney Int       Date:  2018-10-02       Impact factor: 10.612

8.  Collapsing Glomerulopathy: A Single Centre Clinicopathologic Study of Seven Years.

Authors:  Kamal V Kanodia; Aruna V Vanikar; Rashmi D Patel; Kamlesh S Suthar; Lovelesh K Nigam; Himanshu V Patel; Vivek Kute; Hargovind L Trivedi
Journal:  J Clin Diagn Res       Date:  2016-04-01

9.  Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS.

Authors:  Louis-Philippe Laurin; Adil M Gasim; Vimal K Derebail; JulieAnne G McGregor; Jason M Kidd; Susan L Hogan; Caroline J Poulton; Randal K Detwiler; J Charles Jennette; Ronald J Falk; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-21       Impact factor: 8.237

Review 10.  [Virus associated glomerulonephritis].

Authors:  H L Tillmann; A Schwarz
Journal:  Internist (Berl)       Date:  2003-09       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.